Metastatic gastric cancer treatment: a little slow but worthy progress
- PMID: 23335104
- DOI: 10.1007/s12032-013-0464-4
Metastatic gastric cancer treatment: a little slow but worthy progress
Abstract
Metastatic gastric cancer is incurable and remains one of the leading causes of cancer-related deaths around the world. Despite the significant progress in its systemic treatment, metastatic gastric cancer is still a major therapeutic challenge for oncologists. Newer chemotherapy regimens and the addition of molecularly targeted agents to chemotherapy seem to provide better clinical outcomes for patients with metastatic gastric cancer. The objective of this article is to review the current treatment approach for this formidable disease.
Similar articles
-
Chemotherapy in the treatment of metastatic gastric cancer: is there a global standard?Curr Treat Options Oncol. 2011 Mar;12(1):96-106. doi: 10.1007/s11864-010-0135-z. Curr Treat Options Oncol. 2011. PMID: 21274667 Review.
-
Treatment of metastatic esophagus and gastric cancer.Semin Oncol. 2004 Aug;31(4):574-87. doi: 10.1053/j.seminoncol.2004.04.013. Semin Oncol. 2004. PMID: 15297948 Review.
-
Gastric cancer pharmacogenetics: progress or old tripe?Pharmacogenomics. 2013 Jul;14(9):1053-64. doi: 10.2217/pgs.13.88. Pharmacogenomics. 2013. PMID: 23837480 Review.
-
Chemotherapy for metastatic gastric cancer in Japan.Int J Clin Oncol. 2008 Dec;13(6):483-7. doi: 10.1007/s10147-008-0847-2. Epub 2008 Dec 18. Int J Clin Oncol. 2008. PMID: 19093174 Review.
-
New perspectives in the treatment of advanced or metastatic gastric cancer.World J Gastroenterol. 2009 Jun 14;15(22):2689-92. doi: 10.3748/wjg.15.2689. World J Gastroenterol. 2009. PMID: 19522017 Free PMC article.
Cited by
-
Metastatic adenocarcinomas of the stomach or esophagogastric junction (UICC stage IV) are not always a palliative situation: a retrospective analysis.World J Surg. 2014 Feb;38(2):419-25. doi: 10.1007/s00268-013-2293-1. World J Surg. 2014. PMID: 24146196
-
Mevalonate pathway as a novel target for the treatment of metastatic gastric cancer.Oncol Lett. 2020 Dec;20(6):320. doi: 10.3892/ol.2020.12183. Epub 2020 Oct 1. Oncol Lett. 2020. PMID: 33093924 Free PMC article.
-
The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignancies.Cell Prolif. 2018 Aug;51(4):e12449. doi: 10.1111/cpr.12449. Epub 2018 Feb 27. Cell Prolif. 2018. PMID: 29484737 Free PMC article. Review.
-
RNAi-mediated silencing of NOX4 inhibited the invasion of gastric cancer cells through JAK2/STAT3 signaling.Am J Transl Res. 2017 Oct 15;9(10):4440-4449. eCollection 2017. Am J Transl Res. 2017. PMID: 29118906 Free PMC article.
-
Targeted therapy for advanced gastric cancer: A review of current status and future prospects.World J Gastrointest Oncol. 2015 Dec 15;7(12):401-10. doi: 10.4251/wjgo.v7.i12.401. World J Gastrointest Oncol. 2015. PMID: 26690491 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical